Follow-Up of Celiac Disease in Adults: "When, What, Who, and Where"
Details
Publication Year 2023-04-24,Volume 15,Issue #9,Page 2048
Journal Title
Nutrients
Abstract
For patients with celiac disease (CeD), a lifelong gluten-free diet is not a voluntary lifestyle choice-it is a necessity. The key end points in clinical follow-up are symptom resolution, the normalization of weight, prevention of overweight, seroconversion, and negation or minimization of increased long-term morbidity. For the latter, a surrogate endpoint is mucosal healing, which means the normalization of histology to Marsh 0-1. Ideally, celiac follow-up care includes a multidisciplinary approach, effective referral processes, improved access that leverages technological advances, and following guidelines with the identification of measurable quality indicators, ideally informed by evidence-based research. Face-to-face CeD care and telemedicine are considered the standards for this process, although published data are insufficient. Guidelines and statements on diagnosis are readily available. However, data are lacking on optimal clinic visit intervals and outcomes and quality indicators such as improvement of symptoms, function and quality of life, survival and disease control, and how to most effectively use healthcare resources. The results of future research should provide the basis for general recommendations for evidence-based standards of quality of care in CeD.
Publisher
MDPI
Keywords
celiac centers; celiac disease; digital platform; digitalized dietary assessment; eHealth; follow-up; gluten free diet; nutritional education; quality of life
Research Division(s)
Immunology
PubMed ID
37432208
Open Access at Publisher's Site
https://doi.org/10.3390/nu15092048
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-07-21 09:41:27
Last Modified: 2023-07-21 09:46:22
An error has occurred. This application may no longer respond until reloaded. Reload 🗙